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Dear Editor, 
Recent studies conducted in our country show a prev-
alence  of  elevated  lipid  level  or  hyperlipidemia  in 
23.6% of adults aged 20 years and above. Since hy-
perlipidemia is a main risk factor for cardiovascular 
diseases,
1  such  as  atherosclerosis,  cardiac  ischemic 
disorders, and strokes, it is imperative to determine its 
causes. Among the main factors involved in increased 
levels of blood lipids are genetics, a high-fat diet and 
lack of physical exercise. Lately, however, the medi-
cal  community  has  questioned  whether  periodontal 
diseases could be a risk factor for the development of 
hyperlipidemia. Recent studies have suggested such a 
relationship  that  most  literatures  support,
2-5  though 
two studies showed confounding results.
6,7  
In  Iran,  the  prevalence  of  periodontitis  in  40-69 
year olds affects 70% of the general population.
7 Peri-
odontitis is a common oral chronic infection leading to 
gingival inflammation, destruction of periodontal tis-
sues, and deterioration of alveolar bones and finally 
loss  of  teeth.
8  This  disease  develops  when  dental 
plaques release bacteria responsible for the release of 
toxic substances and enzymes from sub-alveolar bacte-
ria groups. Response of the host to the infection leads 
to the local production of cytokines and biological in-
termediates  such  as  prostaglandins  and  systemic  re-
sponses such as the production of antibodies in serum. 
Considering the extent of microbial plaques associated 
with this disease, its chronic nature and local and sys-
temic immunological responses of the host, it is rea-
sonable to assume that periodontal infections affect the 
overall health of a patient and could be involved in the 
development of systemic diseases such as hyperlipo-
proteinemia  and  hypertriglyceridemia.
9  Furthermore, 
several studies have found an association between per-
iodontitis and an increased relative risk for cardiovas-
cular
  disease,  ischemic  stroke,
10  and  coronary  heart 
disease.
11 A probable mechanism by which periodonti-
tis might affect cardiovascular health is chronic oral 
inflammation that may lead to increased blood choles-
terol levels. Total cholesterol and LDL in patients af-
fected by these diseases were higher than those in con-
trol groups.
8 Considering the importance of finding the 
root causes of hyperlipidemia and increasing levels of 
hyperlipidemia in the general population, the aim of 
this study was to investigate the relationship between 
chronic periodontitis and serum lipid levels. 
Our  case-control  study  included  60  patients,  30 
with chronic periodontitis (case group) and 30 healthy 
patients (control group) who referred to the division 
of periodontics, college of dentistry at Qazvin Uni-
versity of Medical Sciences. These two groups were 
paired regarding gender and age; and they were simi-
lar in weight, height, diet, health conditions, and teeth 
number.  Periodontal  states  of  the  two  groups  were 
determined based on the presence of subgingivial and 
supragingival plaques and germs, the presence of at 
least one periodontal pocket with a depth equal to or 
more than 4 mm in each quadrant, and the evidence 
of alveolar bone destruction correlating with plaques 
and calculus as revealed by panoramic radiography. 
The patients had no history of periodontal treat-
ment and six months prior to the study were not af-
flicted with any systemic diseases, taking any medi-
cations to reduce serum lipids and were nonsmokers. 
Total cholesterol, triglyceride, LDL and HDL levels 
were measured in both groups using the enzymatic-
calorimetric method or by single-point measurements 
by the photometry method in terms of mg/dL and the 
role of the diseases with the presentation of  hyper-
lipidemic indices was determined in the patients. Data 
was analyzed using the SPSS software (version 13.0, 
Chicago, IL, USA) via the student t-test. 
The two groups were matched regarding age; thus, 
the average age of the case group was 35.93±5.68 years 
and that of the control group was 34.7±5.59 years. Lev-
els of total cholesterol, triglyceride, HDL and LDL in 
blood serum were measured in both groups and assum-Hamissi et al. 
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ing a normal distribution curve, the average level for the  
two groups were calculated. For cholesterol and triglyc-
eride, the odds ratios were calculated too. 
The average cholesterol amounts were 202.8±33.49 
mg/dl  (case  group)  and  193.46±26.4  mg/dl  (control 
group), with no significant difference (p=0.240). Also, 
normal  and  abnormal  serum  total  cholesterol  and  the 
exposure odds ratio of the case to the control group was 
OR=3.76, 95% CI: 0.91-18.35, which considering the 
incorporation of 1, the odds ratio showed no difference 
from 1. The triglyceride level was 175.5±94.63 mg/dl 
(case group) and 149.5±54.86 (control group), with no 
significant difference (p=0.198). Furthermore, the odds 
ratio was also calculated at OR=1.52, 95% CI: 0.35-
6.95, with no significant difference from 1. 
When comparing HDL between the two groups, 
the  average  was  46.4±7.76  (case  group)  and 
44.12±9.24 mg/dl (control group), showing no signif-
icant difference (p=0.305). HDL levels in all 60 pa-
tients were in the normal range. Regarding LDL, av-
erages  were  reported  as  126.53±31.48  mg/dl  (case 
group) and 119.16±25.83 (control group), again the 
difference was not statistically significant (p=0.327). 
Only one patient in the case group had an LDL level 
above  normal,  while  in  all  other  59  patients,  their 
LDL levels were in the normal range.  
As noted before, an altered lipid profile could be a 
risk factor for various diseases such as atherosclerosis 
and cardiac ischemic disease. However, in our study, 
levels of total cholesterol, triglyceride, LDL and HDL 
exhibited no correlation with periodontal disease. Per-
haps  these  result  discrepancies  are  due  to  different 
sample sizes. Our study was composed of 60 patients 
separated into two groups. In the two groups, a statisti-
cal difference of 0.17 and 0.16 appeared in the HDL 
and LDL levels, respectively. Our results indicated no 
significant statistical difference between the case and 
control groups. Most aforementioned studies have had 
the same problem. Another reason for the discrepancy 
among the results of these studies has been the severity 
of periodontitis in the case groups. In our study the 
design and the mentioned factors were also a problem. 
Another flaw among the existing research has been due 
to the case-control design in which reproducibility was 
difficult and determining the sequence in which perio-
dontal  disease  and  hyperlipidemia  are  exhibited. 
Therefore, even in cases that have lead to a significant 
result, determining if hyperlipidemia has been a risk 
factor  or  outcome  is  difficult  and  it  seems  that  to 
achieve suitable results, different case designs such as 
cohort studies with a larger sample size may lead to 
more reliable results. 
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